This innovative software, CRISPRware, optimizes guide RNA design for genome editing, supporting research on genetic disorders ...

The firm is hoping to show that the RNAi drug can treat HoFH by reducing production of ANGPTL3, which regulates lipid and lipoprotein metabolism.

Results reveal that weight loss has significant effects on cellular processes that are known to affect metabolic health and ...

BACKGROUND: Direct reprogramming of fibroblasts to cardiomyocytes is a potentially curative strategy for ischemic heart ...

Wherefore art thou, MD-bred Romeo? The graded stakes winning Laurel Park-based 2 year old was the record-setting show-topper ...

Kalorama Information, a leading authority in healthcare market research, announces the release of its new report, Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and ...

Being asked to produce a book by an international publishing giant was an exciting milestone for Emeritus Professor Warren ...

ARO-C3 is an investigational RNA interference therapeutic designed to reduce liver production of complement component 3 as a potential therapy for various complement-mediated diseases.

A phase 2 trial reveals that combining intratumoral BO-112 with pembrolizumab shows potential in treating anti–PD-1-resistant ...

The increasing incidence of genetic and rare diseases is a major factor driving revenue growth in the Antisense ...

In April 2025 the Sixth and Final Subject of Cohort 1 was Safely Treated with the Low Dose of BB-301 in the Phase 1b/2a Clinical Treatment Study (NCT06185673)- -Independent Data Safety Monitoring Boar ...

It started as a home-cooked meal, ended in multiple deaths and a court sentence for Erin Patterson. Here's how the death cap ...